Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-331.28%
operating margin TTM
-331.64%
revenue TTM
368.78 Million
revenue per share TTM
0.99$
valuation ratios | |
|---|---|
| pe ratio | -1.13 |
| peg ratio | 0.02 |
| price to book ratio | 19.76 |
| price to sales ratio | 4.58 |
| enterprise value multiple | -1.52 |
| price fair value | 19.76 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -331.64% |
| pretax profit margin | -332.63% |
| net profit margin | -331.28% |
| return on assets | -122.86% |
| return on equity | -813.95% |
| return on capital employed | -283.05% |
liquidity ratios | |
|---|---|
| current ratio | 0.88 |
| quick ratio | 0.88 |
| cash ratio | 0.61 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 56.90 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 56.90 |
| receivables turnover | 6.41 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.29 |
| debt equity ratio | 4.07 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.80 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -3.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.25 |
| cash per share | 0.10 |
| operating cash flow per share | -0.25 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -317.32 |
Frequently Asked Questions
When was the last time Sangamo Therapeutics, Inc. (NASDAQ:SGMO) reported earnings?
Sangamo Therapeutics, Inc. (SGMO) published its most recent earnings results on 06-11-2025.
What is Sangamo Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Sangamo Therapeutics, Inc. (NASDAQ:SGMO)'s trailing twelve months ROE is -813.95%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Sangamo Therapeutics, Inc. (SGMO) currently has a ROA of -122.86%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SGMO's net profit margin stand at?
SGMO reported a profit margin of -331.28% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SGMO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.88 in the most recent quarter. The quick ratio stood at 0.88, with a Debt/Eq ratio of 4.07.